This is an aggregated industry headline. Read the full story at STAT News →
FDA advisory panel narrowly rejects compounding of one peptide, backs two others
Robert F. Kennedy Jr. has lauded peptides and said he takes them himself.
By STAT News
· Jul 24, 2026
· via STAT News
Image: STAT News
RxInsider combines reported facts with industry analysis and informed inference. Forward-looking reads, market commentary, and interpretive framing reflect analysis of available reporting and known facts, not confirmed outcomes.
Tags
theweekformat:headlineheadlineSTAT News
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.
More from The Week
All The Week →
The WeekFiercePharma ↗
As outside experts gathered for a second day to discuss adding certain popular-yet-unapproved peptides to the …
The WeekFierceBiotech ↗
As always, if you know of layoffs occurring at a biotech, please reach out to the Fierce Biotech editorial tea…
The WeekBriefing
Three items stood out this week: U.S. import tariffs on generic drugs, Samsung Biologics pursuing a $1.8 billi…